Reported 11 days ago
Novartis announced it will close its MorphoSys operations in Germany and the United States, affecting 330 jobs as part of a restructuring evaluated after acquiring the company earlier this year. The closures in Munich and Boston are set to be completed by the end of 2025, with the company pledging support for the impacted employees.
Source: YAHOO